| 1 |
A Biomed company aiming to leverage proprietary computational systems
including AI to
accelerate development of novel drug alternatives to life threatening
diseases like
cancer, bacterial infections and muscular dystrophy.
|
AI & Drug Development |
USA |
$20m |
IND |
| 2 |
A Biomed company providing specialised rehabilitation services to treat
patients
suffering from drug addiction and opioid dependence with clinics using
therapies from a
specialised drug. The company is focused on creating a diverse real
estate portfolio
with healthcare and detox related assets whose sole purpose are to
establish turn-key
addiction recovery facilities.
|
Addiction |
Canada |
$5m |
Pre revenue |
| 3 |
A Biomed company that is developing a novel therapeutic class
of
medicines that use the
body's natural immune response to decrease inflammation and stimulate
repair
mechanisms, thereby repairing the damage caused by disease and slowing
aging.
|
Aging |
USA |
$50m |
Phase 3 |
